Daniel Heng Profile
Daniel Heng

@DrDanielHeng

Followers
4K
Following
9K
Media
167
Statuses
2K

A medical oncologist that specializes in and focuses his research on urologic cancers.

Calgary, Alberta
Joined June 2016
Don't wanna be here? Send us removal request.
@DrDanielHeng
Daniel Heng
8 months
We have moved to the Arthur Child Comprehensive Cancer Centre in Calgary! The largest free-standing cancer centre in Canada! $1.4 billion investment in patient care, research and hope. I love our team!⁦@AHS_CancerCare⁩ ⁦@AHS_media⁩ ⁦@UCalgaryMed#YYC #medonc
Tweet media one
Tweet media two
Tweet media three
Tweet media four
8
12
88
@DrDanielHeng
Daniel Heng
3 days
RT @Uromigos: The 4th live Uromigos meeting is happening on 7th & 8th Nov ‘25 in Nashville. It’s going to have an international flavour wit….
0
15
0
@DrDanielHeng
Daniel Heng
4 days
RT @tompowles1: Gem/cis/durvalumab is approved in the EU for muscle invasive bladder cancer (NIAGARA study). It’s the only immune therapy s….
0
60
0
@DrDanielHeng
Daniel Heng
5 days
RT @BraunMDPhD: 1/ Recently, our lab has worked with outstanding groups (#TeamScience) to address some key questions in kidney cancer immun….
0
16
0
@DrDanielHeng
Daniel Heng
6 days
RT @Chrislabaki1: 17/ Next, we use @IMDConline @DrDanielHeng to interrogate the clinical outcomes (TTF, OS, ORR) of patients with metastati….
0
2
0
@DrDanielHeng
Daniel Heng
6 days
RT @DrChoueiri: Bravo @Chrislabaki1 @eddy_saad both now @BIDMC_IM for a landmark paper about Chromophobe Kidney Cancer. A tumor that remain….
0
14
0
@DrDanielHeng
Daniel Heng
6 days
RT @OncoAlert: News From Industry.Source: AstraZeneca. The European Commission has approved AstraZeneca’s Imfinzi (durvalumab) as the first….
0
17
0
@DrDanielHeng
Daniel Heng
9 days
0
2
0
@DrDanielHeng
Daniel Heng
11 days
RT @gu_onc: Risk stratification using the IMDC score
0
2
0
@DrDanielHeng
Daniel Heng
12 days
RT @TiansterZhang: Last week @andyzwang & I published 1st of our translational research in #MolecularCancer @BioMedCentral, developing a mu….
0
15
0
@DrDanielHeng
Daniel Heng
17 days
RT @GillSharlene: Congrats to our all⭐️ faculty for #BOAV25 for breaking down the key #ASCO25 takeaways with a 🇨🇦 West lens 🙏 .@OncEd .@BCC….
0
3
0
@DrDanielHeng
Daniel Heng
21 days
RT @oncodaily: 🏆 The Yvonne Awards 2025 by OncoDaily. @darioT_ | @catgyoung | @oncology_bg | @DKizub | @SKyriakidesEU | @DrDanielHeng | @Ja….
0
10
0
@DrDanielHeng
Daniel Heng
21 days
RT @DrChoueiri: Important, practice-informing study, from @DanaFarber_GU @IMDConline @DrDanielHeng led by our star researcher @yekeduz_emre….
0
9
0
@DrDanielHeng
Daniel Heng
22 days
RT @IKCCorg: Thursday is #WorldKidneyCancerDay! Stay tuned for posts throughout the day, and remember to register for the Global Patient &….
0
3
0
@DrDanielHeng
Daniel Heng
23 days
RT @yekeduz_emre: 🚨 Our new study alert! @ElsevierConnect . What is the role of comorbidity burden in response to immunotherapy based combo….
0
29
0
@DrDanielHeng
Daniel Heng
26 days
RT @DanaFarber: Congratulations to @DrChoueiri on being the recipient of a Doctorate Honoris Causa from The Lebanese University recognizing….
0
16
0
@DrDanielHeng
Daniel Heng
1 month
RT @IKCCorg: Congratulations, very well deserved!.
0
1
0
@DrDanielHeng
Daniel Heng
1 month
RT @PTarantinoMD: In oncology, we don’t usually love overlapping Kaplan-Meier curves. Except that sometimes we really do. Thanks to NSABP-….
0
47
0
@DrDanielHeng
Daniel Heng
1 month
RT @OncEd: Catch up on highlights from the #ASCO25 Congress. Our presenter vignettes feature key takeaways and results from a number of the….
0
1
0
@DrDanielHeng
Daniel Heng
1 month
RT @yekeduz_emre: 🧬 Excellent talk by @ReneeSaliby on sMAdCAM-1 = circulating marker of gut dysbiosis ↔ immune response. ✨Happy to be a par….
0
6
0
@DrDanielHeng
Daniel Heng
1 month
RT @OncoAlert: Dear Colleagues at #ASCO25 .As ALWAYS, it is a pleasure for @OncoAlert 🚨 to be around to capture yet another GREAT @Uromigos….
0
12
0